Safety and Efficacy of Oral Acetyl-l-Carnitine (ALC) in Non-Anemic Potentially Curable Breast Cancer Subjects Undergoing Adjuvant Radiation Therapy Who Have Moderate to Severe Fatigue.
Phase of Trial: Phase II
Latest Information Update: 28 Feb 2017
At a glance
- Drugs Levacecarnine (Primary)
- Indications Fatigue
- Focus Therapeutic Use
- Sponsors Leadiant Biosciences
- 28 Feb 2017 According to a Leadiant Biosciences media release, this trial was originally conducted by Sigma-Tau Pharmaceuticals, Inc. but later on this company's name changed to Leadiant Biosciences
- 05 Jun 2009 Official Title amended as reported by ClinicalTrials.gov.
- 05 Jun 2009 Status changed from recruiting to discontinued as reported by ClinicalTrials.gov.